GOODMIND™ Available for Sale in the United Kingdom and
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...
Source: globenewswire.com
Stay updated with breaking news from Psyence Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...
TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) is pleased to announce that it has...
TORONTO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) ("Psyence" or the "Company"), a life science biotechnology...
Director Resignation...
(2022-05-31 | CSE:PSYG) Psyence Taps Another Pharma Exec to Drive its Clinical Program